- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01768871
Evaluation of the VEGA Knee System® Range of Motion
November 12, 2018 updated by: Aesculap Implant Systems
Prospective, Long-Term, Multi-Center Study on the Efficacy of the VEGA System® for Total Knee Arthroplasty.
The primary objective of this study is to evaluate the function of the knee after a total knee replacement with the VEGA system®.
Study Overview
Status
Terminated
Detailed Description
To evaluate patients after total knee arthroplasty in terms of function for five years.
Study Type
Observational
Enrollment (Actual)
7
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80220
- Rose Medical Center
-
-
Florida
-
Vero Beach, Florida, United States, 32960
- DBA Hussamy Sports and Hand Center
-
-
North Carolina
-
Asheville, North Carolina, United States, 28801
- Charles J DePaolo, MD, PA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who have undergone a total knee arthroplasty with the VEGA knee system®
Description
Inclusion Criteria:
- willing to sign the informed consent.
- Patient has intact collateral ligaments.
Exclusion Criteria:
- Inflammatory arthritis
- Patients that have had a high tibial osteotomy or femoral osteotomy
- Patients with neuromuscular or neurosensory deficiency which would make it difficult to assess the device performance.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WOMAC
Time Frame: Two years
|
WOMAC function score 2 years post arthroplasty
|
Two years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Health related quality of life
Time Frame: Two years
|
Two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Khaled Saleh, Southern Illinois University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
January 14, 2013
First Submitted That Met QC Criteria
January 15, 2013
First Posted (Estimate)
January 16, 2013
Study Record Updates
Last Update Posted (Actual)
November 14, 2018
Last Update Submitted That Met QC Criteria
November 12, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- AAG-O-H-1105
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With Total Knee Arthroplasty Using the VEGA System
-
Zimmer BiometMaisonneuve-Rosemont HospitalCompletedTotal Knee Arthroplasty / Position of Customized X-Ray PSI Guides Using Optical Navigation
-
Mohamed Sayed Mohamed AbbasCompletedSpinal Anesthesia | Total Knee Arthroplasty in Geriatric Patients
-
Security Forces HospitalRecruitingPatients Aged Between 18 and 65years Undergoing Total Knee ArthroplastySaudi Arabia
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingEffect of Postoperative Oral Carbohydrate Administration in Total Knee Arthroplasty Elderly PatientsTotal Knee Arthroplasty | Elderly Patients | Postoperative Recovery | Postoperative Oral CarbohydratesChina
-
Erzurum Technical UniversityActive, not recruitingPatients With Total Knee ArthroplastyTurkey
-
Rush University Medical CenterTerminatedPatients Being Assessed With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson, LexiscanUnited States
-
Medical University of WarsawNot yet recruitingTotal Knee Arthroplasty (TKA) | Osteoarthritis (OA) of the Knee | Knee Pain Arthritis | Robotic Assisted ArthroplastyPoland
-
University College, LondonStryker NordicRecruitingTotal Knee Arthroplasty | Total Knee Replacement | Osteoarthritis (OA) of the Knee | Total Knee Replacement SurgeryUnited Kingdom
-
Taipei Veterans General Hospital, TaiwanCompletedLow-level Laser Acupuncture in Patients With Total Knee ArthroplastyTaiwan
-
Charite University, Berlin, GermanyAesculap AGUnknownRevision Total Knee Arthroplasty Because of | Loosening | Instability | Impingement | or Other Reasons Accepted as Indications for TKA Exchange. | The Focus is to Determine the Precision of Joint Line Restoration in Navigated vs. Conventional Revision Total Knee ArthroplastyGermany